Featured Publications
Association of an Opioid Standard of Practice Intervention With Intravenous Opioid Exposure in Hospitalized Patients
Ackerman AL, O’Connor P, Doyle DL, Marranca SM, Haight CL, Day CE, Fogerty RL. Association of an Opioid Standard of Practice Intervention With Intravenous Opioid Exposure in Hospitalized Patients. JAMA Internal Medicine 2018, 178: 759-763. PMID: 29799964, PMCID: PMC6145746, DOI: 10.1001/jamainternmed.2018.1044.Peer-Reviewed Original ResearchConceptsOpioid exposureParenteral opioidsSubcutaneous routeOpioid dosesPain scoresHospitalized patientsIntervention groupIntravenous administrationDay 1Urban academic medical centerControl periodDoses of opioidsReduced opioid exposureEffective pain controlRate of patientsUse of opioidsDays of hospitalizationHospital day 1General medical unitIntravenous opioid useAcademic medical centerIntravenous opioidsOpioid routesOpioid therapySignificant postintervention
2011
Successful treatment of acute mania and perineal abscess using dexmedetomidine sedation as adjunctive therapy.
Ackerman AL, Mount C. Successful treatment of acute mania and perineal abscess using dexmedetomidine sedation as adjunctive therapy. BMJ Case Reports 2011, 2011 PMID: 22679158, PMCID: PMC3189658, DOI: 10.1136/bcr.07.2011.4543.Peer-Reviewed Original Research
2009
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, Hall-Porter M, Wang F, Ackerman A, Karas RH, Molkentin JD, Patten RD. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circulation Research 2009, 104: 265-75, 11p following 275. PMID: 19074476, PMCID: PMC4427027, DOI: 10.1161/CIRCRESAHA.108.190397.Peer-Reviewed Original Research